Bigner DD - Search Results

1

Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.

Bourdon MA, Coleman RE, Blasberg RG, Groothuis DR, Bigner DD. Bourdon MA, et al. Among authors: bigner dd. Anticancer Res. 1984 May-Jun;4(3):133-40. Anticancer Res. 1984. PMID: 6465851

2

Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.

Colapinto EV, Humphrey PA, Zalutsky MR, Groothuis DR, Friedman HS, de Tribolet N, Carrel S, Bigner DD. Colapinto EV, et al. Among authors: bigner dd. Cancer Res. 1988 Oct 15;48(20):5701-7. Cancer Res. 1988. PMID: 3167830

3

Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: kinetics and implications for diagnosis and therapy.

Blasberg RG, Nakagawa H, Bourdon MA, Groothuis DR, Patlak CS, Bigner DD. Blasberg RG, et al. Among authors: bigner dd. Cancer Res. 1987 Aug 15;47(16):4432-43. Cancer Res. 1987. PMID: 3607773

4

Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.

Lee YS, Bullard DE, Zalutsky MR, Coleman RE, Wikstrand CJ, Friedman HS, Colapinto EV, Bigner DD. Lee YS, et al. Among authors: bigner dd. Cancer Res. 1988 Feb 1;48(3):559-66. Cancer Res. 1988. PMID: 2446747

5

Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.

Lee Y, Bullard DE, Humphrey PA, Colapinto EV, Friedman HS, Zalutsky MR, Coleman RE, Bigner DD. Lee Y, et al. Among authors: bigner dd. Cancer Res. 1988 May 15;48(10):2904-10. Cancer Res. 1988. PMID: 2452014

6

Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.

Zalutsky MR, Moseley RP, Coakham HB, Coleman RE, Bigner DD. Zalutsky MR, et al. Among authors: bigner dd. Cancer Res. 1989 May 15;49(10):2807-13. Cancer Res. 1989. PMID: 2469537

7

Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts.

Skapek SX, Colvin OM, Griffith OW, Groothuis DR, Colapinto EV, Lee Y, Hilton J, Elion GB, Bigner DD, Friedman HS. Skapek SX, et al. Among authors: bigner dd. Biochem Pharmacol. 1988 Nov 15;37(22):4313-7. doi: 10.1016/0006-2952(88)90612-0. Biochem Pharmacol. 1988. PMID: 3196356 Free article.

8

Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs).

Bullard DE, Wikstrand CJ, Humphrey PA, Lee YS, Coleman RE, Zalutsky M, Bigner DD. Bullard DE, et al. Among authors: bigner dd. Nuklearmedizin. 1986 Dec;25(6):210-5. Nuklearmedizin. 1986. PMID: 3808960

9

In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies.

Bullard DE, Adams CJ, Coleman RE, Bigner DD. Bullard DE, et al. Among authors: bigner dd. J Neurosurg. 1986 Feb;64(2):257-62. doi: 10.3171/jns.1986.64.2.0257. J Neurosurg. 1986. PMID: 3944636

10

Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.

Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD. Bourdon MA, et al. Among authors: bigner dd. Cancer Res. 1983 Jun;43(6):2796-805. Cancer Res. 1983. PMID: 6342760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

630 results

Search Page

Filters